SERPINE1 Facilitates Metastasis in Gastric Cancer Through Anoikis Resistance and Tumor Microenvironment Remodeling
Small · 2025
DOI: 10.1002/smll.202500136 ↗Kurz gefasst
Fachartikel in der Zeitschrift Small, 2025. Verfasst von Bofang Wang und 19 weiteren Autor:innen. Beteiligte Einrichtung: The Second Hospital & Clinical Medical School, Lanzhou University, Lanzhou, China. Hauptthemen laut MEDLINE: Tumor Microenvironment, Stomach Neoplasms, Plasminogen Activator Inhibitor 1, Anoikis. Die Arbeit wurde bisher 34-mal zitiert (Crossref) und nennt 64 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Key Project of Science and Technology in Gansu province, Key Talents Project of Gansu Province.
Abstract (Originalsprache)
SERPINE1 is a serine protease inhibitor upregulated in various malignancies and pivotal in gastric cancer (GC) metastasis and the tumor microenvironment (TME). This study elucidates the mechanisms by which SERPINE1 mediates anoikis resistance and fosters an immunosuppressive TME in advanced GC. SERPINE1 is highly expressed in GC tissues and metastatic lesions and serves as an independent risk factor for poor prognosis. The transcriptional activation of SERPINE1 by CEBPB triggers the PI3K/AKT and EMT signaling pathway via autocrine mechanisms, enhancing anoikis resistance and metastatic potential in GC cells. Furthermore, SERPINE1 facilitates M2 macrophage polarization by binding to lipoprotein receptor‐related protein 1 (LRP1) in a paracrine manner, suppressing CD8+ T‐cell infiltration and functionality in the TME. Therapeutic intervention combining SERPINE1 inhibition with PD‐1 blockade exhibits synergistic antitumor effects. Clinically, high SERPINE1 expression is associated with an increased risk of recurrence following immune checkpoint inhibitor therapy in patients with advanced GC. These findings suggest that SERPINE1 is a critical driver of GC progression through anoikis resistance and TME remodeling. Hence, SERPINE1 can offer a promising therapeutic target and represent a predictive biomarker for immunotherapy outcomes in GC.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- The Second Hospital & Clinical Medical School, Lanzhou University, Lanzhou, China.
- Department of Surgical Oncology, The Second Hospital & Clinical Medical School, Lanzhou University, Lanzhou, China.
- Gansu Provincial Key Laboratory of Environmental Oncology, The Second Hospital & Clinical Medical School, Lanzhou University, Lanzhou, China.
- Department of Pathology, The Second Hospital & Clinical Medical School, Lanzhou University, Lanzhou, China.
- Department of Thyroid Surgery, Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.
- Cadre Ward of General Surgery Department, Gansu Provincial Hospital, Lanzhou, China.
ORCID-Profile: Hao Chen
Förderung
- National Natural Science Foundation of China
- Key Project of Science and Technology in Gansu province
- Key Talents Project of Gansu Province
- General Project of Gansu Province Joint Research Fund
- Natural Science Foundation of Gansu Province
- Cuiying Scientific and Technological Innovation Program of Lanzhou University Second Hospital
- Medical Research Innovation Ability Improvement Project of Lanzhou University
- Science and Technology Project of Chengguan District of Lanzhou City
Zitieren
APA
Wang, B., Gu, B., Gao, L., Ma, C., Li, X., Wang, Y., Hu, J., Wang, N., Xiang, L., Yu, Y., Deng, J., Wang, X., He, P., Zou, D., Tao, P., Ma, Y., Song, K., Han, Z., Zhang, T., & Chen, H. (2025). SERPINE1 Facilitates Metastasis in Gastric Cancer Through Anoikis Resistance and Tumor Microenvironment Remodeling. Small. https://doi.org/10.1002/smll.202500136
Vancouver
Wang B, Gu B, Gao L, Ma C, Li X, Wang Y, et al. SERPINE1 Facilitates Metastasis in Gastric Cancer Through Anoikis Resistance and Tumor Microenvironment Remodeling. Small. 2025. doi:10.1002/smll.202500136
BibTeX
@article{Wang2025,
author = {Wang, Bofang and Gu, Baohong and Gao, Lei and Ma, Chenhui and Li, Xuemei and Wang, Yunpeng and Hu, Jike and Wang, Na and Xiang, Lin and Yu, Yang and Deng, Junge and Wang, Xueyan and He, Puyi and Zou, Dan and Tao, Pengxian and Ma, Yanling and Song, Kewei and Han, Zhijian and Zhang, Tao and Chen, Hao},
title = {SERPINE1 Facilitates Metastasis in Gastric Cancer Through Anoikis Resistance and Tumor Microenvironment Remodeling},
journal = {Small},
year = {2025},
doi = {10.1002/smll.202500136}
}
EUVIMED